{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T22:43:23Z","timestamp":1769121803715,"version":"3.49.0"},"reference-count":40,"publisher":"Portland Press Ltd.","issue":"14","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,7,1]]},"abstract":"<jats:p>ARNI [dual AT1 (angiotensin II type\u00a01) receptor\u2013neprilysin inhibition] exerts beneficial effects on blood pressure and kidney function in heart failure, compared with ARB (AT1 receptor blockade) alone. We hypothesized that ARNI improves cardiac and kidney parameters in diabetic TGR(mREN2)27 rats, an angiotensin II-dependent hypertension model. Rats were made diabetic with streptozotocin for 5 or 12\u00a0weeks. In the final 3\u00a0weeks, rats were treated with vehicle, irbesartan (ARB) or irbesartan+thiorphan (ARNI). Blood pressure, measured by telemetry in the 5-week group, was lowered identically by ARB and ARNI. The heart weight\/tibia length ratio in 12-week diabetic animals was lower after ARNI compared with after ARB. Proteinuria and albuminuria were observed from 8\u00a0weeks of diabetes onwards. ARNI reduced proteinuria more strongly than ARB, and a similar trend was seen for albuminuria. Kidneys of ARNI-treated animals showed less severe segmental glomerulosclerosis than those of ARB-treated animals. After 12\u00a0weeks, no differences between ARNI- and ARB-treated animals were found regarding diuresis, natriuresis, plasma endothelin-1, vascular reactivity (acetylcholine response) or kidney sodium transporters. Only ARNI-treated rats displayed endothelin type\u00a0B receptor-mediated vasodilation. In conclusion, ARNI reduces proteinuria, glomerulosclerosis and heart weight in diabetic TGR(mREN2)27 rats more strongly than does ARB, and this occurs independently of blood pressure.<\/jats:p>","DOI":"10.1042\/cs20160197","type":"journal-article","created":{"date-parts":[[2016,4,20]],"date-time":"2016-04-20T01:29:22Z","timestamp":1461115762000},"page":"1209-1220","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Blood pressure-independent renoprotection in diabetic rats treated with AT1 receptor\u2013neprilysin inhibition compared with AT1 receptor blockade alone"],"prefix":"10.1042","volume":"130","author":[{"given":"Lodi\u00a0C.W.","family":"Roksnoer","sequence":"first","affiliation":[{"name":"Division of Pharmacology and Vascular Medicine, Department of Internal Medicine, Erasmus MC, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"van Veghel","sequence":"additional","affiliation":[{"name":"Division of Pharmacology and Vascular Medicine, Department of Internal Medicine, Erasmus MC, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian C.\u00a0Clahsen-","family":"van Groningen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Erasmus MC, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9","family":"de Vries","sequence":"additional","affiliation":[{"name":"Division of Pharmacology and Vascular Medicine, Department of Internal Medicine, Erasmus MC, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid\u00a0M.","family":"Garrelds","sequence":"additional","affiliation":[{"name":"Division of Pharmacology and Vascular Medicine, Department of Internal Medicine, Erasmus MC, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usha\u00a0M.","family":"Bhaggoe","sequence":"additional","affiliation":[{"name":"Division of Pharmacology and Vascular Medicine, Department of Internal Medicine, Erasmus MC, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanette\u00a0M.G.","family":"van Gool","sequence":"additional","affiliation":[{"name":"Division of Pharmacology and Vascular Medicine, Department of Internal Medicine, Erasmus MC, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edith\u00a0C.H.","family":"Friesema","sequence":"additional","affiliation":[{"name":"Division of Pharmacology and Vascular Medicine, Department of Internal Medicine, Erasmus MC, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank\u00a0P.J.","family":"Leijten","sequence":"additional","affiliation":[{"name":"Division of Pharmacology and Vascular Medicine, Department of Internal Medicine, Erasmus MC, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewout\u00a0J.","family":"Hoorn","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Transplantation, Department of Internal Medicine, Erasmus MC, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.H.\u00a0Jan","family":"Danser","sequence":"additional","affiliation":[{"name":"Division of Pharmacology and Vascular Medicine, Department of Internal Medicine, Erasmus MC, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy\u00a0W.","family":"Batenburg","sequence":"additional","affiliation":[{"name":"Division of Pharmacology and Vascular Medicine, Department of Internal Medicine, Erasmus MC, Wytemaweg 80, 3015 CN Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","published-online":{"date-parts":[[2016,6,1]]},"reference":[{"key":"2021113010452572100_B1","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/0024-3205(88)90113-0","article-title":"Intrarenal localization of degradation of atrial natriuretic peptide in isolated glomeruli and cortical nephron segments","volume":"43","author":"Shima","year":"1988","journal-title":"Life Sci."},{"key":"2021113010452572100_B2","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1161\/01.HYP.26.6.1160","article-title":"Comparison of candoxatril and atrial natriuretic factor in healthy men: effects on hemodynamics, sympathetic activity, heart rate variability, and endothelin","volume":"26","author":"Ando","year":"1995","journal-title":"Hypertension"},{"key":"2021113010452572100_B3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1517\/13543784.8.1.79","article-title":"The endopeptidase inhibitor, candoxatril, and its therapeutic potential in the treatment of chronic cardiac failure in man","volume":"8","author":"McDowell","year":"1999","journal-title":"Expert Opin. Investig. Drugs"},{"key":"2021113010452572100_B4","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0140-6736(09)61966-8","article-title":"Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study","volume":"375","author":"Ruilope","year":"2010","journal-title":"Lancet"},{"key":"2021113010452572100_B5","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/S0140-6736(12)61227-6","article-title":"The angiotensin receptor neprilysin inhibitor LCZ696\u00a0in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial","volume":"380","author":"Solomon","year":"2012","journal-title":"Lancet"},{"key":"2021113010452572100_B6","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin\u2013neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"2021113010452572100_B7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2337\/db06-1180","article-title":"Treatment of streptozotocin-induced diabetic rats with AVE7688, a vasopeptidase inhibitor: effect on vascular and neural disease","volume":"56","author":"Davidson","year":"2007","journal-title":"Diabetes"},{"key":"2021113010452572100_B8","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/ejhf.232","article-title":"Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696\u00a0in patients with heart failure and preserved ejection fraction","volume":"17","author":"Voors","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"2021113010452572100_B9","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/324473a0","article-title":"Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney","volume":"324","author":"Marin-Grez","year":"1986","journal-title":"Nature"},{"key":"2021113010452572100_B10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1042\/cs0830445","article-title":"Determinants of intra-individual variation in kidney function in normoalbuminuric insulin-dependent diabetic patients: importance of atrial natriuretic peptide and glycaemic control","volume":"83","author":"Pedersen","year":"1992","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113010452572100_B11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1046\/j.1365-2362.1999.00422.x","article-title":"Atrial natriuretic peptide increases albuminuria in type\u00a0I diabetic patients: evidence for blockade of tubular protein reabsorption","volume":"29","author":"Jacobs","year":"1999","journal-title":"Eur. J. Clin. Invest."},{"key":"2021113010452572100_B12","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1210\/jcem.84.7.5819","article-title":"Plasma brain natriuretic peptide levels in normotensive noninsulin-dependent diabetic patients with microalbuminuria","volume":"84","author":"Yano","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2021113010452572100_B13","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1161\/01.CIR.0000112582.16683.EA","article-title":"Impact of obesity on plasma natriuretic peptide levels","volume":"109","author":"Wang","year":"2004","journal-title":"Circulation"},{"key":"2021113010452572100_B14","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1210\/jc.2011-2425","article-title":"Low plasma level of atrial natriuretic peptide predicts development of diabetes: the prospective Malmo Diet and Cancer study","volume":"97","author":"Magnusson","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2021113010452572100_B15","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/344541a0","article-title":"Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene","volume":"344","author":"Mullins","year":"1990","journal-title":"Nature"},{"key":"2021113010452572100_B16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/ki.1992.4","article-title":"Transgenic rats carrying the mouse renin gene: morphological characterization of a low-renin hypertension model","volume":"41","author":"Bachmann","year":"1992","journal-title":"Kidney Int."},{"key":"2021113010452572100_B17","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/0895-7061(96)00099-4","article-title":"Renal and antihypertensive effects of neutral endopeptidase inhibition in transgenic rats with an extra renin gene","volume":"9","author":"Stasch","year":"1996","journal-title":"Am. J. Hypertens."},{"key":"2021113010452572100_B18","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1046\/j.1523-1755.1998.00019.x","article-title":"A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR)","volume":"54","author":"Kelly","year":"1998","journal-title":"Kidney Int."},{"key":"2021113010452572100_B19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/ki.2015.107","article-title":"Optimum AT receptor\u2013neprilysin inhibition has superior cardioprotective effects compared with AT receptor blockade alone in hypertensive rats","volume":"88","author":"Roksnoer","year":"2015","journal-title":"Kidney Int."},{"key":"2021113010452572100_B20","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1097\/HJH.0b013e32833d01ae","article-title":"Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats","volume":"28","author":"van Esch","year":"2010","journal-title":"J. Hypertens."},{"key":"2021113010452572100_B21","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1161\/01.HYP.29.6.1240","article-title":"Renin\u2013angiotensin system components in the interstitial fluid of the isolated perfused rat heart. Local production of angiotensin I","volume":"29","author":"de Lannoy","year":"1997","journal-title":"Hypertension"},{"key":"2021113010452572100_B22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1161\/01.HYP.24.1.37","article-title":"Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis","volume":"24","author":"Danser","year":"1994","journal-title":"Hypertension"},{"key":"2021113010452572100_B23","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int."},{"key":"2021113010452572100_B24","doi-asserted-by":"publisher","first-page":"F1177","DOI":"10.1152\/ajprenal.00201.2013","article-title":"K+-induced natriuresis is preserved during Na+ depletion and accompanied by inhibition of the Na+\u2013Cl\u2212 cotransporter","volume":"305","author":"van der Lubbe","year":"2013","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"2021113010452572100_B25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1161\/01.RES.41.1.19","article-title":"Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats","volume":"41","author":"Mulvany","year":"1977","journal-title":"Circ. Res."},{"key":"2021113010452572100_B26","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0008-6363(99)00249-7","article-title":"Vasoconstriction by in situ formed angiotensin II: role of ACE and chymase","volume":"44","author":"MaassenVanDenBrink","year":"1999","journal-title":"Cardiovasc. Res."},{"key":"2021113010452572100_B27","doi-asserted-by":"publisher","first-page":"F377","DOI":"10.1152\/ajprenal.00143.2002","article-title":"Concerted action of ENaC, Nedd4-2, and Sgk1\u00a0in transepithelial Na+ transport","volume":"283","author":"Kamynina","year":"2002","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"2021113010452572100_B28","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1161\/01.HYP.0000125698.00128.64","article-title":"Integrating drug pharmacokinetics for phenotyping individual renin response to angiotensin II blockade in humans","volume":"43","author":"Azizi","year":"2004","journal-title":"Hypertension"},{"key":"2021113010452572100_B29","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1097\/HJH.0b013e32834c627a","article-title":"Renal responses to three types\u00a0of renin\u2013angiotensin system blockers in patients with diabetes mellitus on a high-salt diet: a need for higher doses in diabetic patients?","volume":"29","author":"Hollenberg","year":"2011","journal-title":"J. Hypertens"},{"key":"2021113010452572100_B30","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/0196-9781(91)90132-9","article-title":"In\u00a0vitro degradation of endothelin-1 by endopeptidase 24.11 (enkephalinase)","volume":"12","author":"Fagny","year":"1991","journal-title":"Peptides"},{"key":"2021113010452572100_B31","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1152\/physrev.00030.2006","article-title":"Regulatory binding partners and complexes of NHE3","volume":"87","author":"Donowitz","year":"2007","journal-title":"Physiol. Rev."},{"key":"2021113010452572100_B32","doi-asserted-by":"crossref","first-page":"R2132","DOI":"10.1152\/ajpregu.2000.279.6.R2132","article-title":"Role of NO and cytochrome P-450-derived eicosanoids in ET-1-induced changes in intrarenal hemodynamics in rats","volume":"279","author":"Hercule","year":"2000","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"2021113010452572100_B33","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1681\/ASN.V351131","article-title":"Vasoactive substances induce cytoskeletal changes in cultured rat glomerular epithelial cells","volume":"3","author":"Sharma","year":"1992","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021113010452572100_B34","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1113\/jphysiol.2001.012929","article-title":"NO donors potentiate the beta-adrenergic stimulation of ICa,L and the muscarinic activation of IK,ACh in rat cardiac myocytes","volume":"540","author":"Abi-Gerges","year":"2002","journal-title":"J. Physiol."},{"key":"2021113010452572100_B35","doi-asserted-by":"publisher","first-page":"H85","DOI":"10.1152\/ajpheart.00311.2011","article-title":"Coronary microvascular dysfunction in a porcine model of early atherosclerosis and diabetes","volume":"302","author":"van den Heuvel","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2021113010452572100_B36","doi-asserted-by":"publisher","first-page":"R710","DOI":"10.1152\/ajpregu.00286.2012","article-title":"Hyperfiltration and effect of nitric oxide inhibition on renal and endothelial function in humans with uncomplicated type\u00a01 diabetes mellitus","volume":"303","author":"Cherney","year":"2012","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"2021113010452572100_B37","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00424-013-1407-9","article-title":"The sodium chloride cotransporter SLC12A3: new roles in sodium, potassium, and blood pressure regulation","volume":"466","author":"Moes","year":"2014","journal-title":"Pflugers Arch."},{"key":"2021113010452572100_B38","doi-asserted-by":"publisher","first-page":"6153","DOI":"10.1074\/jbc.M610636200","article-title":"Epithelial Na+ channels are fully activated by furin- and prostasin-dependent release of an inhibitory peptide from the \u03b3-subunit","volume":"282","author":"Bruns","year":"2007","journal-title":"J. Biol. Chem."},{"key":"2021113010452572100_B39","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00424-012-1104-0","article-title":"Aldosterone does not require angiotensin II to activate NCC through a WNK4\u2013SPAK-dependent pathway","volume":"463","author":"van der Lubbe","year":"2012","journal-title":"Pflugers Arch."},{"key":"2021113010452572100_B40","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/j.jacc.2008.07.062","article-title":"Myocardial steatosis is an independent predictor of diastolic dysfunction in type\u00a02 diabetes mellitus","volume":"52","author":"Rijzewijk","year":"2008","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/130\/14\/1209\/447878\/cs1301209.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/130\/14\/1209\/447878\/cs1301209.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T11:33:37Z","timestamp":1638272017000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/130\/14\/1209\/71478\/Blood-pressure-independent-renoprotection-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,1]]},"references-count":40,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2016,7,1]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20160197","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,1]]}}}